BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 14566972)

  • 1. JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways.
    Ren Z; Kar S; Wang Z; Wang M; Saavedra JE; Carr BI
    J Cell Physiol; 2003 Dec; 197(3):426-34. PubMed ID: 14566972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous NO induces apoptosis of hepatocellular carcinoma cells via positive p38/JNK signaling pathway and negative ERK signaling pathways.
    Liu L; Xing Y; Cao M; Xu J; Chen J
    Mol Cell Biochem; 2021 Apr; 476(4):1651-1661. PubMed ID: 33420899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways.
    Liu SL; Lin X; Shi DY; Cheng J; Wu CQ; Zhang YD
    Arch Biochem Biophys; 2002 Oct; 406(2):173-82. PubMed ID: 12361705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous shift in transcriptional profile of explanted glomeruli via activation of the MAP kinase family.
    Ishikawa Y; Konta T; Kitamura M
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F954-9. PubMed ID: 11053056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial heat shock protein-60 increases epithelial cell proliferation through the ERK1/2 MAP kinases.
    Zhang L; Pelech SL; Mayrand D; Grenier D; Heino J; Uitto VJ
    Exp Cell Res; 2001 May; 266(1):11-20. PubMed ID: 11339820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells.
    Watabe M; Ito K; Masuda Y; Nakajo S; Nakaya K
    Oncogene; 1998 Feb; 16(6):779-87. PubMed ID: 9488042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes.
    Taimor G; Rakow A; Piper HM
    FASEB J; 2001 Nov; 15(13):2518-20. PubMed ID: 11641266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.
    Liu J; Li C; Qu W; Leslie E; Bonifant CL; Buzard GS; Saavedra JE; Keefer LK; Waalkes MP
    Mol Cancer Ther; 2004 Jun; 3(6):709-14. PubMed ID: 15210857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.